nach oben

Journal of Gastrointestinal Surgery

Erschienen in:

01.06.2010 | Review Article

Periampullary and Duodenal Neoplasms in Neurofibromatosis Type 1: Two Cases and an Updated 20-Year Review of the Literature Yielding 76 Cases

verfasst von: Daniel Relles, Jennie Baek, Agnieszka Witkiewicz, Charles J. Yeo

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Patients with neurofibromatosis type 1 (NF1) are at increased risk to develop tumors throughout the gastrointestinal tract, including neuromas, gastrointestinal stromal tumors (GIST), and periampullary somatostatin-rich carcinoids. Here, we briefly describe two male patients with NF1 and review the recent literature on this topic.

Methods

Databases for PubMed and MEDLINE were searched for English-language articles since 1989 using a list of keywords, as well as references from review articles.

Results

The results generated by the search yielded 50 articles and 74 cases. Patients most commonly presented with jaundice, weight loss, GI bleeding, or anemia. The mean age at presentation was 47.9 years, with 59% of patients being female. Mean tumor size was 3.8 cm (range 0.9–27 cm). Tumor location was the duodenum (60%), ampulla (31%), pancreas (5%), or bile duct/gallbladder (4%). Tumor type was reported as somatostatinoma (40%), GIST (34%), adenocarcinoma (8%), carcinoid (6%), neurofibroma (5%), schwannoma (4%), or gangliocytic paraganglioma (3%). Treatment included classic Whipple procedure (42%), local excision (25%), pylorus-preserving pancreaticoduodenectomy (17%), and other resection (6%). Mean follow-up was 31 months postresection (range 0–99 months): 75% of patients were alive with no evidence of disease.

Conclusions

These results underscore the importance of a thorough evaluation for tumors in NF1 patients with gastrointestinal symptoms, as well as subsequent surgical management when findings suggest a tumor in the periampullary region, as resection remains the mainstay of treatment.

Klein A, Clemens J, Cameron J. Periampullary neoplasms in von Recklinghausen’s disease. Surgery 1989;106(5):815–819.PubMed

Giuly JA, Picand R, Giuly D, Monges B, Nguyen-Cat R. Von Recklinghausen disease and gastrointestinal stromal tumors. Am J Surg 2003;185(1):86–87.CrossRefPubMed

Pinsk I, Dukhno O, Ovnat A, Levy I. Gastrointestinal complications of von Recklinghausen’s disease: two case reports and a review of the literature. Scand J Gastroenterol 2003;38(12):1275–1278.CrossRefPubMed

Cheng SP, Huang MJ, Yang TL, Tzen CY, Liu CL, Liu TP, Hsiao SC. Neurofibromatosis with gastrointestinal stromal tumors: insights into the association. Dig Dis Sci 2004;49(7–8):1165–1169.CrossRefPubMed

Seymour-Dempsey K, Andrassy RJ. Neurofibromatosis: implications for the general surgeon. J Am Coll Surg 2002;195(4):553–563.CrossRefPubMed

Fuller CE, Williams GT. Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen’s disease). Histopathology 1991;19(1):1–11.CrossRefPubMed

Miettinen M, Fetsch JF, Sobin LH, Lasota J. Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol 2006;30(1):90–96.CrossRefPubMed

Teramoto S, Ota T, Maniwa A, Matsui T, Itaya N, Aoyagi K, Kusanagi H, Narita M. Two von Recklinghausen’s disease cases with pheochromocytomas and gastrointestinal stromal tumors (GIST) in combination. Int J Urol 2007;14(1):73–74.CrossRefPubMed

Zöller ME, Rembeck B, Odén A, Samuelsson M, Angervall L. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer 1997;79(11):2125–2131.CrossRefPubMed

10.

Kang DY, Park CK, Choi JS, Jin SY, Kim HJ, Joo M, Kang MS, Moon WS, Yun KJ, Yu ES, Kang H, Kim KM. Multiple gastrointestinal stromal tumors: clinicopathologic and genetic analysis of 12 patients. Am J Surg Pathol 2007;31(2):224–232.CrossRefPubMed

11.

Kinoshita K, Hirota S, Isozaki K, Ohashi A, Nishida T, Kitamura Y, Shinomura Y, Matsuzawa Y. Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients. J Pathol 2004;202(1):80–85.CrossRefPubMed

12.

Nemoto H, Tate G, Schirinzi A, Suzuki T, Sasaya S, Yoshizawa Y, Midorikawa T, Mitsuya T, Dallapiccola B, Sanada Y. Novel NF1 gene mutation in a Japanese patient with neurofibromatosis type 1 and a gastrointestinal stromal tumor. J Gastroenterol 2006;41(4):378–382.CrossRefPubMed

13.

Stewart DR, Corless CL, Rubin BP, Heinrich MC, Messiaen LM, Kessler LJ, Zhang PJ, Brooks DG. Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1. J Med Genet 2007;44(1):e61.CrossRefPubMed

14.

Andersson J, Sihto H, Meis-Kindblom JM, Joensuu H, Nupponen N, Kindblom LG. NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics. Am J Surg Pathol 2005;29(9):1170–1176.CrossRefPubMed

15.

Takazawa Y, Sakurai S, Sakuma Y, Ikeda T, Yamaguchi J, Hashizume Y, Yokoyama S, Motegi A, Fukayama M. Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen’s disease). Am J Surg Pathol 2005;29(6):755–763.CrossRefPubMed

16.

Maertens O, Prenen H, Debiec-Rychter M, Wozniak A, Sciot R, Pauwels P, De Wever I, Vermeesch JR, de Raedt T, De Paepe A, Speleman F, van Oosterom A, Messiaen L, Legius E. Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Hum Mol Genet 2006;15(6):1015–1023.CrossRefPubMed

17.

Kalender ME, Sevinc A, Tutar E, Sirikci A, Camci C. Effect of sunitinib on metastatic gastrointestinal stromal tumor in patients with neurofibromatosis type 1: a case report. World J Gastroenterol 2007;13(18):2629–2632.PubMed

18.

Ricci JL. Carcinoid of the ampulla of Vater. Local resection or pancreaticoduodenectomy. Cancer 1993;71(3):686–690.CrossRefPubMed

19.

Costi R, Caruana P, Sarli L, Violi V, Roncoroni L, Bordi C. Ampullary adenocarcinoma in neurofibromatosis type 1. Case report and literature review. Mod Pathol 2001;14(11):1169–1174.CrossRefPubMed

20.

Scully R. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 15-1989. A 52-year-old man with neurofibromatosis and jaundice. N Engl J Med 1989;320(15):996–1004.CrossRef

21.

Hatzitheoklitos E, Büchler MW, Friess H, Poch B, Ebert M, Mohr W, Imaizumi T, Beger HG. Carcinoid of the ampulla of Vater. Clinical characteristics and morphologic features. Cancer 1994;73(6):1580–1588.CrossRefPubMed

22.

Rämö OJ, Ristkari SK, Miettinen M, Järvi K, Mokka RE. Duodenal carcinoid tumour with psammoma bodies: a rare cause of haematemesis. Eur J Surg 1997;163(3):227–230.PubMed

23.

Cantor AM, Rigby CC, Beck PR, Mangion D. Neurofibromatosis, phaeochromocytoma, and somatostatinoma. Br Med J (Clin Res Ed) 1982;285(6355):1618–1619.CrossRef

24.

Usui M, Matsuda S, Suzuki H, Hirata K, Ogura Y, Shiraishi T. Somatostatinoma of the papilla of Vater with multiple gastrointestinal stromal tumors in a patient with von Recklinghausen’s disease. J Gastroenterol 2002;37(11):947–953.CrossRefPubMed

25.

Kainuma O, Ito Y, Taniguchi T, Shimizu T, Nakada H, Date Y, Hara T. Ampullary somatostatinoma in a patient with von Recklinghausen’s disease. J Gastroenterol 1996;31(3):460–464.CrossRefPubMed

26.

Tan CC, Hall RI, Semeraro D, Irons RP, Freeman JG. Ampullary somatostatinoma associated with von Recklinghausen’s neurofibromatosis presenting as obstructive jaundice. Eur J Surg Oncol 1996;22(3):298–301.CrossRefPubMed

27.

Tanaka S, Yamasaki S, Matsushita H, Ozawa Y, Kurosaki A, Takeuchi K, Hoshihara Y, Doi T, Watanabe G, Kawaminami K. Duodenal somatostatinoma: a case report and review of 31 cases with special reference to the relationship between tumor size and metastasis. Pathol Int 2000;50(2):146–152.CrossRefPubMed

28.

Hartel M, Wente MN, Sido B, Friess H, Büchler MW. Carcinoid of the ampulla of Vater. J Gastroenterol Hepatol 2005;20(5):676–681.CrossRefPubMed

29.

Mao C, Shah A, Hanson DJ, Howard JM. Von Recklinghausen’s disease associated with duodenal somatostatinoma: contrast of duodenal versus pancreatic somatostatinomas. J Surg Oncol 1995;59(1):67–73.CrossRefPubMed

30.

O’Brien TD, Chejfec G, Prinz RA. Clinical features of duodenal somatostatinomas. Surgery 1993;114(6):1144–1147.PubMed

31.

Mayoral W, Salcedo J, Al-Kawas F. Ampullary carcinoid tumor presenting as acute pancreatitis in a patient with von Recklinghausen’s disease: case report and review of the literature. Endoscopy 2003;35(10):854–857.CrossRefPubMed

32.

Cappelli C, Agosti B, Braga M, Cumetti D, Gandossi E, Rizzoni D, Agabiti Rosei E. Von Recklinghausen’s neurofibromatosis associated with duodenal somatostatinoma. A case report and review of the literature. Minerva Endocrinol 2004;29(1):19–24.PubMed

33.

Miettinen M, Kopczynski J, Makhlouf HR, Sarlomo-Rikala M, Gyorffy H, Burke A, Sobin LH, Lasota J. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol 2003;27(5):625–641.CrossRefPubMed

34.

Miettinen M, Lasota J. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics. Pol J Pathol 2003;54(1):3–24.PubMed

35.

Min KW, Balaton AJ. Small intestinal stromal tumors with skeinoid fibers in neurofibromatosis: report of four cases with ultrastructural study of skeinoid fibers from paraffin blocks. Ultrastruct Pathol 1993;17(3–4):307–314.CrossRefPubMed

36.

Ishida T, Wada I, Horiuchi H, Oka T, Machinami R. Multiple small intestinal stromal tumors with skeinoid fibers in association with neurofibromatosis 1 (von Recklinghausen’s disease). Pathol Int 1996;46(9):689–695.CrossRefPubMed

37.

Trupiano JK, Stewart RE, Misick C, Appelman HD, Goldblum JR. Gastric stromal tumors: a clinicopathologic study of 77 cases with correlation of features with nonaggressive and aggressive clinical behaviors. Am J Surg Pathol 2002;26(6):705–714.CrossRefPubMed

38.

Nikfarjam M, McLean C, Muralidharan V, Christophi C. Neuroendocrine tumours of the ampulla of Vater. ANZ J Surg 2002;72(7):531–533.CrossRefPubMed

39.

Lee JL, Kim JY, Ryu MH, Kang HJ, Chang HM, Kim TW, Lee H, Park JH, Kim HC, Kim JS, Kang YK. Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1. Dig Dis Sci 2006;51(6):1043–1046.CrossRefPubMed

40.

Clements WM, Martin SP, Stemmerman G, Lowy AM. Ampullary carcinoid tumors: rationale for an aggressive surgical approach. J Gastrointest Surg 2003;7(6):773–776.CrossRefPubMed

41.

House MG, Yeo CJ, Schulick RD. Periampullary pancreatic somatostatinoma. Ann Surg Oncol 2002;9(9):869–874.CrossRefPubMed

42.

Bakker JR, Haber MM, Garcia FU. Gastrointestinal neurofibromatosis: an unusual cause of gastric outlet obstruction. Am Surg 2005;71(2):100–105.PubMed

43.

Behranwala KA, Spalding D, Wotherspoon A, Fisher C, Thompson JN. Small bowel gastrointestinal stromal tumours and ampullary cancer in type 1 neurofibromatosis. World J Surg Oncol 2004;2:1.CrossRefPubMed

44.

Bettini R, Falconi M, Crippa S, Capelli P, Boninsegna L, Pederzoli P. Ampullary somatostatinomas and jejunal gastrointestinal stromal tumor in a patient with Von Recklinghausen’s disease. World J Gastroenterol 2007;13(19):2761–2763.PubMed

45.

Borobia FG, Fabregat J, Jorba R, Poves I, Biondo S, Serrano T, Figueras J, Jaurrieta E. Exocrine pancreatic insufficiency caused by a somatostatinoma of the minor and major duodenal papilla in a patient with neurofibromatosis. Eur J Surg 2001;167(2):154–156.CrossRefPubMed

46.

Burke AP, Sobin LH, Shekitka KM, Federspiel BH, Helwig EB. Somatostatin-producing duodenal carcinoids in patients with von Recklinghausen’s neurofibromatosis. A predilection for black patients. Cancer 1990;65(7):1591–1595.CrossRefPubMed

47.

Castoldi L, De Rai P, Marini A, Ferrero S, De Luca VM, Tiberio G. Neurofibromatosis-1 and ampullary gangliocytic paraganglioma causing biliary and pancreatic obstruction. Int J Pancreatol 2001;29(2):93–97.CrossRefPubMed

48.

Ching CK, Greer AJ. Metachronous biliary tract cancers in a patient with von Recklinghausen’s disease. Am J Gastroenterol 1993;88(7):1124–1125.PubMed

49.

Colarian J, Pietruk T, LaFave L, Calzada R. Adenocarcinoma of the ampulla of Vater associated with neurofibromatosis. J Clin Gastroenterol 1990;12(1):118–119.CrossRefPubMed

50.

Coombs RJ. Case of the season. Malignant neurogenic tumor of duodenum and pancreas. Semin Roentgenol 1990;25(2):127–129.CrossRefPubMed

51.

Farr CM, Price HM, Bezmalinovic Z. Duodenal somatostatinoma with congenital pseudoarthrosis. J Clin Gastroenterol 1991;13(2):195–197.PubMed

52.

Fendrich V, Ramaswamy A, Slater EP, Bartsch DK. Duodenal somatostatinoma associated with Von Recklinghausen’s disease. J Hepatobiliary Pancreat Surg 2004;11(6):417–421.CrossRefPubMed

53.

Fujisawa T, Osuga T, Maeda M, Sakamoto N, Maeda T, Sakaguchi K, Onishi Y, Toyoda M, Maeda H, Miyamoto K, Kawaraya N, Kusumoto C, Nishigami T. Malignant endocrine tumor of the pancreas associated with von Recklinghausen’s disease. J Gastroenterol 2002;37(1):59–67.CrossRefPubMed

54.

Fung JW, Lam KS. Neurofibromatosis and insulinoma. Postgrad Med J 1995;71(838):485–486.CrossRefPubMed

55.

Gallinger S, Aronson M, Shayan K, Ratcliffe EM, Gerstle JT, Parkin PC, Rothenmund H, Croitoru M, Baumann E, Durie PR, Weksberg R, Pollett A, Riddell RH, Ngan BY, Cutz E, Lagarde AE, Chan HS. Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germ line homozygous MLH1 mutation. Gastroenterology 2004;126(2):576–585.CrossRefPubMed

56.

Green BT, Rockey DC. Duodenal somatostatinoma presenting with complete somatostatinoma syndrome. J Clin Gastroenterol 2001;33(5):415–417.CrossRefPubMed

57.

Hagen EC, Houben GM, Nikkels RE, Jansen JB, Lamers CB, Gooszen HG, van Duinen SG, Meinders AE. Exocrine pancreatic insufficiency and pancreatic fibrosis due to duodenal somatostatinoma in a patient with neurofibromatosis. Pancreas 1992;7(1):98–104.CrossRefPubMed

58.

Hendi JM, Horton KM, Fishman EK. Somatostatinoma of the ampulla and appendical carcinoid in a patient with von Recklinghausen disease. J Comput Assist Tomogr 2005;29(3):418–419.CrossRefPubMed

59.

Hünerbein M, Dohmoto M, Haensch W, Schlag PM. Biliary obstruction caused by a multifocal duodenal neurosarcoma in a patient with von Recklinghausen’s disease. Endoscopy 1996;28(4):405–406.CrossRefPubMed

60.

Joo YE, Kim HS, Choi SK, Rew JS, Park CS, Kim SJ. Primary duodenal adenocarcinoma associated with neurofibromatosis type 1. J Gastroenterol 2002;37(3):215–219.CrossRefPubMed

61.

Juergens KU, Weckesser M, Bettendorf O, Wormanns D. Duodenal somatostatinoma and gastrointestinal stromal tumor associated with neurofibromatosis type 1: diagnosis with PET/CT. AJR Am J Roentgenol 2006;187(2):W233–W234.CrossRefPubMed

62.

Karatzas G, Kouraklis G, Karayiannakis A, Patapis P, Givalos N, Kaperonis E. Ampullary carcinoid and jejunal stromal tumour associated with von Recklinghausen’s disease presenting as gastrointestinal bleeding and jaundice. Eur J Surg Oncol 2000;26(4):428–429.CrossRefPubMed

63.

Leung VK, Lee SW, Yuen NW, Kung NN, Loke TK. Epigastric pain in a patient with neurofibromatosis type 1. Hong Kong Med J 2005;11(3):213–215.PubMed

64.

Martin FM, Rossi RL, Dorrucci V, Silverman ML, Braasch JW. Clinical and pathologic correlations in patients with periampullary tumors. Arch Surg 1990;125(6):723–726.PubMed

65.

Mendes-Ribeiro HK, Woodham C. CT demonstration of an unusual cause of biliary obstruction in a patient with peripheral neurofibromatosis. Clin Radiol 2000;55(10):796–798.CrossRefPubMed

66.

O’Hanlon DM, Fenlon HM, McEntee GP. Gangliocytic paraganglioma of the duodenum. J Am Coll Surg 2001;192(6):794.CrossRefPubMed

67.

Ohtsuki Y, Sonobe H, Mizobuchi T, Takahashi K, Hayashi K, Iwata J, Tahara E. Duodenal carcinoid (somatostatinoma) combined with von Recklinghausen’s disease. A case report and review of the literature. Acta Pathol Jpn 1989;39(2):141–146.PubMed

68.

Samonakis DN, Quaglia A, Joshi NM, Tibballs JM, Nagree A, Triantos CK, Davies N, Standish R, Dhillon AP, Davidson BR, Burroughs AK, Caplin ME. Obstructive jaundice secondary to neuroendocrine tumour in a patient with von Recklinghausen’s disease. Eur J Gastroenterol Hepatol 2005;17(11):1229–1232.CrossRefPubMed

69.

Sakorafas GH, Giannopoulos GA, Parasi A, Konstantoudakis G, Tzanakis N, Stergiopoulos S, Peros G. Large somatostatin-producing endocrine carcinoma of the ampulla of Vater in association with GIST in a patient with von Recklinghausen’s disease. Case report and review of the literature. JOP 2008;9(5):633–639.PubMed

70.

South CD, Baird MA, Marsh WL Jr. Clinical challenges and images in GI Ampullary somatostatinoma associated with neurofibromatosis type 1, presenting with iron-deficiency anemia. Gastroenterology 2009;136(1):51, 368.CrossRefPubMed

71.

Suzuki S, Sato K, Katada E, Kuno Y, Mizoguchi N, Tokuda H, Inaguma S, Asamoto M, Dohi Y. Periampullary somatostatinoma and multiple gastrointestinal stromal tumors associated with von Recklinghausen’s disease. J Gastroenterol 2004;39(10):1011–1012.CrossRefPubMed

72.

Thornton MR, Campbell F, Garvey CJ, Hershman MJ. Abdominal neurofibromatosis. J R Soc Med 1999;92(11):587–589.PubMed

73.

Walsh MM, Brandspigel K. Gastrointestinal bleeding due to pancreatic schwannoma complicating von Recklinghausen’s disease. Gastroenterology 1989;97(6):1550–1551.PubMed

74.

Winfield RD, Hochwald SN, Vogel SB, Hemming AW, Liu C, Cance WG, Grobmyer SR. Presentation and management of gastrointestinal stromal tumors of the duodenum. Am Surg 2006;72(8):719–722, discussion 722–723.PubMed

75.

Yantiss RK, Rosenberg AE, Sarran L, Besmer P, Antonescu CR. Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular study. Mod Pathol 2005;18(4):475–484.CrossRefPubMed

76.

Yoshida A, Hatanaka S, Ohi Y, Umekita Y, Yoshida H. von Recklinghausen’s disease associated with somatostatin-rich duodenal carcinoid (somatostatinoma), medullary thyroid carcinoma and diffuse adrenal medullary hyperplasia. Acta Pathol Jpn 1991;41(11):847–856.PubMed

Titel: Periampullary and Duodenal Neoplasms in Neurofibromatosis Type 1: Two Cases and an Updated 20-Year Review of the Literature Yielding 76 Cases
verfasst von: Daniel Relles
Jennie Baek
Agnieszka Witkiewicz
Charles J. Yeo
Publikationsdatum: 01.06.2010
Verlag: Springer-Verlag
Erschienen in: Journal of Gastrointestinal Surgery / Ausgabe 6/2010
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-009-1123-0

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2010

A Meta-Analysis of Randomized Controlled Trials that Compared Laparoscopy-Assisted and Open Distal Gastrectomy for Early Gastric Cancer

Ileal Pouch Prolapse: Prevalence, Management, and Outcomes

Impact of Splenectomy on Thrombocytopenia, Chemotherapy, and Survival in Patients with Unresectable Pancreatic Cancer

Anastomotic Sealing by Extracellular Matrices (ECM) Improves Healing of Colonic Anastomoses in the Critical Early Phase

Optimal Technical Management of Stump Closure Following Distal Pancreatectomy: A Retrospective Review of 215 Cases

Gastric Venous Reconstruction After Radical Pancreatic Surgery: Case Report and Review of the Literature

Update Chirurgie